Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.
Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalli MA, Bradford PA. Bouchillon SK, et al. Among authors: dowzicky mj. Int J Antimicrob Agents. 2004 Aug;24(2):119-24. doi: 10.1016/j.ijantimicag.2004.01.010. Int J Antimicrob Agents. 2004. PMID: 15288309
In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
Bouchillon SK, Hoban DJ, Johnson BM, Johnson JL, Hsiung A, Dowzicky MJ; Tigecycline Evaluation and Surveillance Trial (TEST) Group. Bouchillon SK, et al. Among authors: dowzicky mj. Diagn Microbiol Infect Dis. 2005 Jul;52(3):173-9. doi: 10.1016/j.diagmicrobio.2005.06.004. Diagn Microbiol Infect Dis. 2005. PMID: 16105561
In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).
Hoban DJ, Bouchillon SK, Johnson BM, Johnson JL, Dowzicky MJ; Tigecycline Evaluation and Surveillance Trial (TEST Program) Group. Hoban DJ, et al. Among authors: dowzicky mj. Diagn Microbiol Infect Dis. 2005 Jul;52(3):215-27. doi: 10.1016/j.diagmicrobio.2005.06.001. Diagn Microbiol Infect Dis. 2005. PMID: 16105567
Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
Hoban DJ, Bouchillon SK, Dowzicky MJ. Hoban DJ, et al. Among authors: dowzicky mj. Diagn Microbiol Infect Dis. 2007 Apr;57(4):423-8. doi: 10.1016/j.diagmicrobio.2006.10.013. Diagn Microbiol Infect Dis. 2007. PMID: 17403448
In vitro activity of tigecycline against molecularly characterised strains of Enterobacteriaceae isolated from phase 3 clinical trials and the Tigecycline Evaluation and Surveillance Trial (TEST).
Biedenbach DJ, Hackel MA, Quintana A, Wible M, Dowzicky MJ, McGovern PC, Bouchillon SK. Biedenbach DJ, et al. Among authors: dowzicky mj. J Glob Antimicrob Resist. 2015 Dec;3(4):311-312. doi: 10.1016/j.jgar.2015.09.004. Epub 2015 Oct 22. J Glob Antimicrob Resist. 2015. PMID: 27842883 No abstract available.
79 results